1-8 of 8
Rozemarijn S. van Rijn
Close
Sort by
Journal Articles

DA-EPOCH-R for High Grade B-Cell Lymphoma Patients with MYC and BCL2 and/or BCL6 Rearrangements: Clinical Results of the Induction Phase of the HOVON-152 Trial

A.Vera de Jonge, Marie José Kersten, Erik van Werkhoven, Marjolein van der Poel, Koen de Heer, Clara Klerk, Yorick Sandberg, Rozemarijn S Van Rijn, Rob Fijnheer, Pim Mutsaers, Vibeke Vergote, Djamila Issa, Aart Beeker, Yavuz M. Bilgin, Lara H. Böhmer, Laurens Nieuwenhuizen, Wendy Stevens, Roel JW van Kampen, Rogier Mous, Marc Durian, Tjeerd Snijders, Joost S.P Vermaat, Otto Visser, Josée M. Zijlstra, Henk Hofwegen, Helma G.J.M. Zanders, Liping P. Fu, Daphne De Jong, Marcel Nijland, Martine E.D. Chamuleau
Journal: Blood
Blood (2023) 142 (Supplement 1): 3090.
https://doi.org/10.1182/blood-2023-181707
Published: 2023
Journal Articles

Patients with Relapsed Large B-Cell Lymphoma after 12 Months Have a Similarly Poor Prognosis As Patients with a Relapse before 12 Months

Hilde T Van Der Galien, Hilde AM Kooistra, Robby Kibbelaar, Nic JGM Veeger, Marcel Nijland, Geert A. Huls, Tom Van Meerten, Rozemarijn S Van Rijn
Journal: Blood
Blood (2023) 142 (Supplement 1): 444.
https://doi.org/10.1182/blood-2023-185993
Published: 2023
Journal Articles

Development of an Effective Safety Switch for Selective Elimination of Human T Cells In Vivo after Adoptive Transfer.

Tom van Meerten, BSc, Henk Rozemuller, PhD, Wendy J.M. Mackus, PhD, Paul W.H.I. Parren, PhD, Jan G.J. van de Winkel, PhD, Marie-Jose Claessen, MSc, Rozemarijn S. van Rijn, MD, Anton Hagenbeek, MD PhD, Anton C.M. Martens, PhD, Saskia B. Ebeling, PhD
Journal: Blood
Blood (2006) 108 (11): 5488.
https://doi.org/10.1182/blood.V108.11.5488.5488
Published: 2006
Journal Articles

Induction of Xenogeneic Graft-Versus-Host Disease through Administration of HuPBMC to Immune Deficient RAG2 −/− γc −/− Mice: A Model for B Cell-Involvement in Chronic Graft-Versus-Host Disease.

Marijke C. Canninga-van Dijk, MD, PhD, Rozemarijn S. van Rijn, MD, Elles R. Simonetti, BSc, Marieke C. Hogenes, MD, Saskia Smulders, BSc, Roel A. de Weger, PhD, Anton Hagenbeek, MD, PhD, Jan G. van de Tweel, MD, PhD, Leo F. Verdonck, MD, PhD, Anton C.M. Martens, PhD, Saskia B. Ebeling, PhD
Journal: Blood
Blood (2005) 106 (11): 3099.
https://doi.org/10.1182/blood.V106.11.3099.3099
Published: 2005
Journal Articles

Complement-Induced Cell Death by Rituximab Depends on CD20-Expression Level and Acts Complementary to Antibody-Dependent Cell-Mediated Cytotoxicity.

Tom van Meerten, PhD, Rozemarijn S. van Rijn, MD, Anton Hagenbeek, Prof, MD, Saskia B. Ebeling, PhD
Journal: Blood
Blood (2005) 106 (11): 775.
https://doi.org/10.1182/blood.V106.11.775.775
Published: 2005
Journal Articles

Human CD4 + CD25 + Regulatory T Cells Effectively Control Xenogeneic-GvHD Induced by Autologous T Cells in Rag2 −/− γc −/− Immune-Deficient Mice.

Tuna Mutis, MD, PhD, Rozemarijn S. van Rijn, MD, Elles R. Simonetti, Tineke Aarts, Maarten Emmelot, Saskia B. Ebeling, PhD
Journal: Blood
Blood (2004) 104 (11): 301.
https://doi.org/10.1182/blood.V104.11.301.301
Published: 2004
Journal Articles

Quantitative Assessment of the Impact of Ex Vivo Manipulation on the In Vivo Functionality of Human T Cells in RAG2 −/− γ c −/− mice.

Rozemarijn S. van Rijn, MD, Elles R. Simonetti, Gert Storm, PhD, Mark Bonyhadi, PhD, Anton Hagenbeek, MD, PhD, Anton C.M. Martens, PhD, Saskia B. Ebeling, PhD
Journal: Blood
Blood (2004) 104 (11): 450.
https://doi.org/10.1182/blood.V104.11.450.450
Published: 2004
Journal Articles

A new xenograft model for graft-versus-host disease by intravenous transfer of human peripheral blood mononuclear cells in RAG2 -/- γc -/- double-mutant mice

Rozemarijn S. van Rijn, Elles R. Simonetti, Anton Hagenbeek, Marieke C. H. Hogenes, Roel A. de Weger, Marijke R. Canninga-van Dijk, Kees Weijer, Hergen Spits, Gert Storm, Louis van Bloois, Ger Rijkers, Anton C. M. Martens, Saskia B. Ebeling
Journal: Blood
Blood (2003) 102 (7): 2522–2531.
https://doi.org/10.1182/blood-2002-10-3241
Published: 2003